EUVIMEDEUVIMED entdecken
Crossref

Nasal carriage of virulent and multidrug resistant Staphylococcus aureus: a possible comorbidity of COVID-19

Muinah Adenike Fowora, Adenike Aiyedogbon, Ibilola Omolopo, Ahmed Oluwasegun Tajudeen, Faustina Onyeaghasiri, Idowu Edu-Muyideen, Abdul-Lateef Olatunde Olanlege, Aminah Abioye, Tajudeen Akanji Bamidele, Toyosi Raheem, Adesegun Adesesan, Bamidele Iwalokun und 1 weitere

Molecular Biology Reports · 2024

DOI: 10.1007/s11033-024-09578-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Muinah Adenike Fowora und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Biotechnology, Nigerian Institute of Medical Research, Lagos, Nigeria. muinahj@yahoo.com. Hauptthemen laut MEDLINE: COVID-19, Staphylococcal Infections, Staphylococcus aureus, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Nigerian Institute of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Staphylococcus aureus (S. aureus) associated with COVID-19 has not been well documented. This cross-sectional study evaluated the association between nasal S. aureus carriage and COVID-19. METHODS AND RESULTS: Nasopharyngeal samples were collected from 391 participants presenting for COVID-19 test in Lagos, Nigeria, and S. aureus was isolated from the samples. Antimicrobial susceptibility test was done by disc diffusion method. All S. aureus isolates were screened for the presence of mecA, panton-valentine leucocidin (PVL) and toxic shock syndrome toxin (TSST) virulence genes by polymerase chain reaction. Staphylococcal protein A (spa) typing was conducted for all the isolates. Participants with COVID-19 had double the prevalence of S. aureus (42.86%) compared to those who tested negative (20.54%). A significant association was seen between S. aureus nasal carriage and COVID-19 (p = 0.004). Antimicrobial sensitivity results showed resistance to oxacillin (100%), cefoxitin (53%), and vancomycin (98.7%). However, only 41% of the isolates harbored the mecA gene, with SCCmecV being the most common SCCmec type. There was no association between the carriage of virulence genes and COVID-19. A total of 23 Spa types were detected, with t13249 and t095 being the two most common spa types. CONCLUSION: This study examined the association between nasal S. aureus carriage and SARS-COV-2 infection. Further research is required to fully explore the implications of S. aureus co-infection with COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Staphylococcal InfectionsStaphylococcus aureusSARS-CoV-2HumansCross-Sectional StudiesMaleFemaleAdultMiddle AgedBacterial ToxinsMethicillin-Resistant Staphylococcus aureusComorbidityBacterial ProteinsVirulenceNigeriaDrug Resistance, Multiple, BacterialAnti-Bacterial AgentsCarrier StateMicrobial Sensitivity TestsPenicillin-Binding ProteinsLeukocidinsExotoxinsVirulence Factors

Stichwörter der Autor:innen

S. aureusCOVID-19CoinfectionSCCmecSpa types

Substanzen

Bacterial ToxinsBacterial ProteinsAnti-Bacterial AgentsmecA protein, Staphylococcus aureusPenicillin-Binding ProteinsLeukocidinsExotoxinsPanton-Valentine leukocidinVirulence Factors

Autor:innen und Institutionen

  • Department of Molecular Biology and Biotechnology, Nigerian Institute of Medical Research, Lagos, Nigeria. muinahj@yahoo.com.
  • Department of Molecular Biology and Biotechnology, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • FOWM Biotechnology Laboratories, Lagos, Nigeria.
  • Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Department of Science Laboratory Technology, Faculty of Science, Lagos State University, Lagos, Nigeria.
  • Infectious Diseases Hospital, Lagos, Nigeria.

Förderung

  • Nigerian Institute of Medical Research

Zitieren

APA

Fowora, M. A., Aiyedogbon, A., Omolopo, I., Tajudeen, A. O., Onyeaghasiri, F., Edu-Muyideen, I., Olanlege, A. O., Abioye, A., Bamidele, T. A., Raheem, T., Adesesan, A., Iwalokun, B., & Salako, B. L. (2024). Nasal carriage of virulent and multidrug resistant Staphylococcus aureus: a possible comorbidity of COVID-19. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09578-3

Vancouver

Fowora MA, Aiyedogbon A, Omolopo I, Tajudeen AO, Onyeaghasiri F, Edu-Muyideen I, et al. Nasal carriage of virulent and multidrug resistant Staphylococcus aureus: a possible comorbidity of COVID-19. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09578-3

BibTeX
@article{Fowora2024,
  author = {Fowora, Muinah Adenike and Aiyedogbon, Adenike and Omolopo, Ibilola and Tajudeen, Ahmed Oluwasegun and Onyeaghasiri, Faustina and Edu-Muyideen, Idowu and Olanlege, Abdul-Lateef Olatunde and Abioye, Aminah and Bamidele, Tajudeen Akanji and Raheem, Toyosi and Adesesan, Adesegun and Iwalokun, Bamidele and Salako, Babatunde Lawal},
  title = {Nasal carriage of virulent and multidrug resistant Staphylococcus aureus: a possible comorbidity of COVID-19},
  journal = {Molecular Biology Reports},
  year = {2024},
  doi = {10.1007/s11033-024-09578-3}
}
Kostenlos starten →